Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 278
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 10  |  Issue : 5  |  Page : 2041-2043

Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: A case series

Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, OneWorld Community Health Centers, Inc., Omaha, Nebraska, USA

Correspondence Address:
Dr. Jessica M Downes
986145 Nebraska Medical Center, Suite 2043, Omaha - 69198-6145, Nebraska
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jfmpc.jfmpc_2271_20

Rights and Permissions

Three independent cases of adult patients are described who had relative control of their type 2 diabetes prior to infection with COVID-19. Each of the described patients had different levels of severity of COVID-19 but all experienced significant and prolonged hyperglycemia for at least 1–2 months after resolution of their COVID-19 infection. Two of the three patients required intensifying insulin regimens for two months after COVID-19 infection. The case study helps to inform primary care providers about the possible need for the intensification of antihyperglycemic medications for several weeks to months after the resolution of COVID-19 infection to minimize prolonged hyperglycemia.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal